Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Clinical trial NCT07492927 · RECRUITING

Trial details

NCT number: NCT07492927
Sponsor: Xijing Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Clinically Significant Prostate Cancer

Start date: 2021-03-12
Primary completion: 2026-12-31
Enrollment: 1700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.